False-Positive HIV Test Results More Likely Among Patients With Active COVID-19
Researchers examined whether patients with PCR-positive COVID-19 infection are more likely to have false-positive results for HIV infection via fourth-generation assay.
Researchers examined whether patients with PCR-positive COVID-19 infection are more likely to have false-positive results for HIV infection via fourth-generation assay.
Researchers compared neurocognitive function among patients with vs without HIV infection.
While Medicare covers a range of services, relatively high cost-sharing requirements exist for some beneficiaries, especially those with HIV.
Researchers examined antibody responses among immunosuppressed patients following receipt of a third dose of either the mRNA-1273 or BNT162b2 vaccine.
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
The HIV medications are all manufactured by ViiV Healthcare, a GlaxoSmithKline.
Syphilis diagnoses have continued to accelerate for the past few years due to COVID-19 pandemic-related restrictions at sexual health clinics.
The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks.
The legal action follows an investigation that identified counterfeit products being sold by distributors not authorized to sell Janssen’s medicines.
In this meta-analysis, researched compared the diagnostic accuracy point-of-care HIV RNA viral load tests with laboratory-based assays to detect antiretroviral therapy treatment failure in patients with HIV infection.